Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV/AIDS Vaccines: 2018.

Clinical pharmacology and therapeutics - 1 Dec 2018

Robinson Harriet L

Abstract excerpt

Human immunodeficiency virus (HIV) has infected 76 million people and killed an estimated 35 million. During its 40-year history, remarkable progress has been made on antiretroviral drugs. Progress toward a vaccine has also been made, although this has yet to deliver a licensed product. In 2007, I wrote a review, HIV AIDS Vaccines: 2007. This review, HIV AIDS Vaccines: 2018, focuses on the progress in the past 11...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Development

Share to HIV Antibodies

Share to HIV Antigens

Share to Host-Pathogen Interactions

Share to Research Design

Source

Open in PubMed Open full text

Identifiers

PMID: 30099743
DOI: 10.1002/cpt.1208
PMCID: PMC6282490

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV/AIDS Vaccines: 2018.PMID 30099743Read ↗

Assessment of HIV vaccine development: past, present, and future.Semantic proximity Read ↗

[HIV vaccine].Semantic proximity Read ↗

[Advances in AIDS vaccines].Semantic proximity Read ↗

Translational research insights from completed HIV vaccine efficacy trials.Semantic proximity Read ↗

[Designing an effective AIDS vaccine: strategies and current status].Semantic proximity Read ↗

HIV immunology better understood and vaccination attempts started.Semantic proximity Read ↗

Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteersSemantic proximity Read ↗

AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.Semantic proximity Read ↗

Preparing for the availability of a partially effective HIV vaccine: some lessons from other licensed vaccines.Semantic proximity Read ↗

HIV/AIDS: Current Updates on the Disease, Treatment and PreventionSemantic proximity Read ↗

Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.Semantic proximity Read ↗

[HIV vaccine: how far along are we?]Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.